ACELYRIN, INC Valuation
| SLRN Stock | USD 4.73 0.03 0.64% |
At this time, the entity appears to be undervalued. ACELYRIN, INC Common shows a prevailing Real Value of $11.67 per share. The current price of the entity is $4.73. Our model approximates the value of ACELYRIN, INC Common from evaluating the entity fundamentals such as number of shares shorted of 4.7 M, and Current Valuation of (84.28 M) as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting ACELYRIN, INC's valuation include:
Price Book 0.8926 | Enterprise Value -84.3 M | Enterprise Value Ebitda 0.456 |
Undervalued
Today
Please note that ACELYRIN, INC's price fluctuation is slightly risky at this time. Calculation of the real value of ACELYRIN, INC Common is based on 3 months time horizon. Increasing ACELYRIN, INC's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since ACELYRIN, INC is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ACELYRIN, Stock. However, ACELYRIN, INC's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.73 | Real 11.67 | Target 33.0 | Hype 4.74 | Naive 4.35 |
The intrinsic value of ACELYRIN, INC's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence ACELYRIN, INC's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of ACELYRIN, INC Common helps investors to forecast how ACELYRIN, stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ACELYRIN, INC more accurately as focusing exclusively on ACELYRIN, INC's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use ACELYRIN, INC's intrinsic value based on its ongoing forecasts of ACELYRIN, INC's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against ACELYRIN, INC's closest peers.
ACELYRIN, INC Cash |
|
ACELYRIN, Valuation Trend
Knowing ACELYRIN, INC's actual value is paramount for traders when making sound investment determinations. Using both ACELYRIN, INC's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
ACELYRIN, INC Total Value Analysis
ACELYRIN, INC Common is at this time projected to have valuation of (84.28 M) with market capitalization of 471.53 M, debt of 1.19 M, and cash on hands of . The negative valuation of ACELYRIN, INC may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the ACELYRIN, INC fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(84.28 M) | 471.53 M | 1.19 M |
ACELYRIN, INC Asset Utilization
One of the ways to look at asset utilization of ACELYRIN, is to check how much profit was generated for every dollar of assets it reports. ACELYRIN, INC Common shows a negative utilization of assets of -0.33 percent, losing $0.003289 for each dollar of assets held by the entity. Inadequate asset utilization signifies that the company is being less proficient with each dollar of assets it shows. Put another way, asset utilization of ACELYRIN, INC Common shows how discouraging it operates for each dollar spent on its assets.ACELYRIN, INC Ownership Allocation
ACELYRIN, INC holds a total of 100.33 Million outstanding shares. The majority of ACELYRIN, INC Common outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in ACELYRIN, INC Common to benefit from reduced commissions. Therefore, institutional investors are subject to a different set of regulations than regular investors in ACELYRIN, INC. Please pay attention to any change in the institutional holdings of ACELYRIN, INC Common as this could imply that something significant has changed or is about to change at the company. Also note that nearly seven million five hundred four thousand three hundred eighty-five invesors are currently shorting ACELYRIN, INC expressing very little confidence in its future performance.ACELYRIN, INC Profitability Analysis
Net Loss for the year was (381.64 M) with profit before overhead, payroll, taxes, and interest of 0.About ACELYRIN, INC Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of ACELYRIN, INC Common. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of ACELYRIN, INC Common based exclusively on its fundamental and basic technical indicators. By analyzing ACELYRIN, INC's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of ACELYRIN, INC's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of ACELYRIN, INC. We calculate exposure to ACELYRIN, INC's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ACELYRIN, INC's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -103.5 K | -108.7 K |
ACELYRIN, INC Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 70.2 M |
ACELYRIN, INC Current Valuation Indicators
ACELYRIN, INC's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final ACELYRIN, INC's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as ACELYRIN, INC, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use ACELYRIN, INC's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes ACELYRIN, INC's worth.When determining whether ACELYRIN, INC Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ACELYRIN, INC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Acelyrin, Inc Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Acelyrin, Inc Common Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in ACELYRIN, INC Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ACELYRIN, INC. If investors know ACELYRIN, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ACELYRIN, INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.46) | Return On Assets (0.33) | Return On Equity (0.42) |
The market value of ACELYRIN, INC Common is measured differently than its book value, which is the value of ACELYRIN, that is recorded on the company's balance sheet. Investors also form their own opinion of ACELYRIN, INC's value that differs from its market value or its book value, called intrinsic value, which is ACELYRIN, INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACELYRIN, INC's market value can be influenced by many factors that don't directly affect ACELYRIN, INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ACELYRIN, INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if ACELYRIN, INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACELYRIN, INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.